US Patent Issued to Convergent Health Sciences on Dec. 23 for "Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables" (Colorado Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,713, issued on Dec. 23, was assigned to Convergent Health Sciences LLC (Boulder, Colo.).

"Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables" was invented by C. Russell Thomas (Boulder, Colo.) and Douglas G. Metcalf (Boulder, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various aspects of this disclosure relate to the discovery that phosphatase and laccase enzymes confound the extraction and quantification of psilocybin and other tryptamines during the preparation of psilocybin-containing products from mushrooms. Various aspects of this disclosure relate to the discovery th...